Posters & Publications

USING TARGETED RADIOTHERAPY IN HIGHLY REFRACTORY MULTIPLE MYELOMA: IOPOFOSINE I 131

SNMMI Conference 2023

Targeted Delivery Platform, Iopofosine I 131

Moving Beyond Solid Tumors: A Novel Radiotherapy in Hematologic Cancers

13th Annual World ADC Conference

Targeted Delivery Platform, Iopofosine I 131

CLR 131 (Iopofosine I-131) Treatment in Triple Class Refractory and Beyond Multiple Myeloma Patients: Preliminary Efficacy and Safety Results from the Phase 2 CLOVER-1 Trial

Sikander Ailawadhi, MD, Patrick Stiff, MD, Emad Ibrahim, MBBCh, MD, Damian J. Green, MD, Brea Lipe, MD, Elizabeth H. Cull, MD, Natalie S. Callander, MD, John Friend, MD, Jarrod Longcor and Kate Oliver, BS

Targeted Delivery Platform, Iopofosine I 131, PDCs

Treatment Free Remission (TFR) and Overall Response Rate (ORR) Results in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia (WM) Treated with CLR 131

S Ailawadhi2, A Chanan Khan2 , J Peterson2, J Longcor1, K Oliver1, M Brown1, J Friend1 , DJ Green3

Iopofosine I 131

Targeted treatment of multiple myeloma with a radioiodinated small molecule radiopharmaceutical

Ankita Shahi , Gerald E. Weiss , Saswati Bhattacharya , Dana C. Baiu , Roberta Marino , Taner Pula , Natalie S. Callander , Fotis Asimakopoulos & Mario Otto (2021)

Targeted Delivery Platform, Iopofosine I 131, CLR1404

Targeted Treatment Supplemental Document

Ankita Shahi1#, Gerald E. Weiss1#, Saswati Bhattacharya2 , Dana C. Baiu3 , Roberta Marino4 , Taner Pula5 , Natalie S. Callander2 , Fotis Asimakopoulos2,6, and Mario Otto1

Targeted Delivery Platform, Iopofosine I 131, CLR1404

CLR 131 in Patients with Relapsed or Refractory Pediatric Malignancies

Puccetti D, Otto M, Morgenstern D,DeSantes K,Cho SY, Hall L, Oliver K, Longcor J

Iopofosine I 131

Fluorescent Cancer-Selective Alkylphosphocholine Analogs for Intraoperative Glioma Detection

Neurosurgery V76, Issue 2, pp. 115-124 -February 2015 - A Peer Reviewed Publication

CLR 1502

Phospholipid Ether Analogs for the Detection of Colorectal Tumors

PLOS ONE V9, Issue 10 - October, 2014 - Peer Reviewed Publication

CLR 1502

A novel "diapeutic" molecular imaging agent for combined oncologic diagnosis and therapy in a broad spectrum of human cancers: Preliminary clinical experience with CLR1404

American Society of Clinical Oncology (ASCO) 2014 Annual Meeting Oral Presentation - Pickhardt - UW - June 2014

Targeted Delivery Platform, CLR 124

American Society of Clinical Oncology (ASCO) 2014 Annual Meeting Oral Presentation - Pickhardt - UW - June 2014

American Society of Clinical Oncology (ASCO) 2014 Annual Meeting Oral Presentation - Pickhardt - UW - June 2014

Iopofosine I 131

American Society of Clinical Oncology (ASCO) 2014 Annual Meeting Poster - Lubner - UW - June 2014

American Society of Clinical Oncology (ASCO) 2014 Annual Meeting Poster - Lubner - UW - June 2014

Iopofosine I 131

Cancer-Targeted Diapeutics: Radioiodinated Phospholipid Ether Analogs for Broad-Spectrum Imaging and Therapy

EMIT: Targeted Radiotherapy Oral Presentation - Pazoles - Novelos - January 2013

Targeted Delivery Platform, Iopofosine I 131, CLR 124, CLR 1502

Molecular Diapeutics: Phospholipid Ether Analogs as Broad-Spectrum Cancer and Cancer Stem Cell Detection and Treatment

Imaging in 2020 Oral Presentation - Weichert - UW - October 2012

Targeted Delivery Platform, Iopofosine I 131, CLR 124, CLR 1502

Relative Biodistribution and Tumor Uptake of I-131-CLR1404, in Human Subjects with Advanced Colon Cancer

WMIC Poster Presentation - Liu - UW - September 2012

Targeted Delivery Platform, Iopofosine I 131, CLR 124

Relative Biodistribution and Tumor Uptake of I-124-CLR1404, in Humans with Non-Small Cell Lung Cancer

WMIC Poster Presentation - Traynor - UW - September 2012

Targeted Delivery Platform

First in Human Use of I-124-CLR1404, PET/CT in Primary and Metastatic Brain Tumors

WMIC Poster Presentation - Weichert - UW - September 2012

Targeted Delivery Platform, CLR 124

I-131-CLR1404 and CLR1404: Broad spectrum, cancer-targeted molecular radio- and chemotherapeutic phospholipid ether analogs

AACR Poster Presentation - Weichert - UW - April 2012

Targeted Delivery Platform, Iopofosine I 131

I-124-CLR1404 and I-131-CLR1404: Broad spectrum diapeutic agents for cancer cell-targeted PET imaging and molecular radiotherapy

AACR Poster Presentation - Weichert - UW - April 2012

Targeted Delivery Platform, Iopofosine I 131, CLR 124

Fluorescent Alkyl Phospholipid Analogs for Fluorescence Imaging of Tumors in vitro and in vivo

WMIC Poster Presentation - Weichert - UW - September 2009

Targeted Delivery Platform, CLR 1502

Synthesis and Structure-Activity Relationship Effects on the Tumor Avidity of Radioiodinated Phospholipid Ether Analogues

Journal of Medicinal Chemistry V49, pp. 2155-2165 - April, 2006 - Peer Reviewed Publication

Targeted Delivery Platform, Iopofosine I 131, CLR 124

Tumor-specific alkylphosphocholine analogs were evaluated as imaging and therapy agents in patients and in animal models of human cancer.

Alkylphosphocholine Analogs for Broad Spectrum Cancer Imaging and Therapy

Targeted Delivery Platform